The effect of pH on polymorph formation of the pharmaceutically active compound tianeptine

International Journal of Pharmaceutics

Volumn 432, Issue 1-2, 2012, Pages 50-56

  Orola, Liana ^a   Veidis, Mikelis V ^a   Sarcevica, Inese ^a,b   Actins, Andris ^a   Belyakov, Sergey ^b   Platonenko, Aleksandrs ^a  

^a UNIVERSITY OF LATVIA   (Latvia)

^b LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

Author keywords

Crystal structure; Crystallization; pH; Polymorph; Tianeptine; X ray diffractometry

Indexed keywords

AMPHOLYTE; CARBOXYLIC ACID; TIANEPTINE;

ARTICLE; CHEMICAL STRUCTURE; CRYSTAL STRUCTURE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; HYDROGEN BOND; PH; PRIORITY JOURNAL; X RAY POWDER DIFFRACTION;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; CRYSTALLIZATION; HYDROGEN-ION CONCENTRATION; POWDER DIFFRACTION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; THIAZEPINES; X-RAY DIFFRACTION;

EID: 84861582679     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.04.061     Document Type: Article

References (30)

1. A. Altomare, G. Cascarano, G. Giacovazzo, A. Guagliardi, M.C. Burla, G. Polidori, and M. Camalli SIR92 - a program for automatic solution of crystal structures by direct methods J. Appl. Crystallogr. 27 1994 435
2. P.W. Betteridge, J.R. Carruthers, R.I. Cooper, K. Prout, and D.J. Watkin CRYSTALS version 12: software for guided crystal structure analysis J. Appl. Crystallogr. 36 2003 1487
3. A. Bouchard, N. Jovanović, G.W. Hofland, E. Mendes, D.J.A. Crommelin, W. Jiskoot, and G.J. Witkamp Selective production of polymorphs and pseudomorphs using supercritical fluid crystallization from aqueous solutions Cryst. Growth Des. 7 2007 1432 1440
4. 2, by neutron diffraction Acta Crystallogr. C 41 1985 441 443
5. M.J. Buerger Crystal-structure aspects of phase transformations Trans. Am. Crystallogr. Assoc. 7 1971 1 23
6. S.L. Childs, L.J. Chyall, J.T. Dunlap, D.A. Coates, B.C. Stahly, and G.P. Stahly A metastable polymorph of metformin hydrochloride: isolation and characterization using capillary crystallization and thermal microscopy techniques Cryst. Growth Des. 4 2004 441 449
7. L.J. Chyall, J.M. Tower, D.A. Coates, T.L. Houston, and S.L. Childs Polymorph generation in capillary spaces: the preparation and structural analysis of a metastable polymorph of nabumetone Cryst. Growth Des. 2 2002 505 510
8. M.A. Deij, T. Vissers, H. Meekes, and E. Vlieg Toward rational design of tailor-made additives using growth site statistics Cryst. Growth Des. 7 2007 778 786
9. L. Du-Cuny, J. Huwyler, H. Fischer, and M. Kansy A potentiometric titration method for the crystallization of drug-like organic molecules Int. J. Pharm. 342 2007 161 167
10. L.J. Farrugia WinGX suite for small-molecule single-crystal crystallography J. Appl. Crystallogr. 32 1999 837 838
11. A.L. Grzesiak, and A.J. Matzger New form discovery for the analgesics flurbiprofen and sulindac facilitated by polymer-induced heteronucleation J. Pharm. Sci. 96 2007 2978 2986
12. Guzman, H., Popov, A., Rammeloo, T.J.L., Remenar, J., Saoud, J.B., Tawa, M., 2010. Tianeptine sulfate salt forms and methods of making and using same. US Patent No. 20,100,112,051 A1 20100506.
13. S. Hamad, C.C. Moon, C.R.A. Catlow, A.T. Hulme, and S.L. Price Kinetic insights into the role of the solvent in the polymorphism of 5-fluorouracil from molecular dynamics simulations J. Phys. Chem. B 110 2006 3323 3329
14. J.L. Hilden, C.E. Reyes, M.J. Kelm, J.S. Tan, J.G. Stowell, and K.R. Morris Capillary precipitation of a highly polymorphic organic compound Cryst. Growth Des. 3 2003 921 926
15. R. Hilfiker, S.M. De Paul, and M. Szelagiewicz Approaches to polymorphism screening R. Hilfiker, Polymorphism: In the Pharmaceutical Industry 2006 Wiley-VCH Weinheim 287 308
16. S. Jiang, P.J. Jansens, and J.H. ter Horst Control over polymorph formation of o-aminobenzoic acid Cryst. Growth Des. 10 2010 2541 2547
17. 2O Latv. PSR Zinat. Akad. Vestis Kim. Ser. 2 1983 215 218 (in Russian)
18. M. Kitamura Strategy for control of crystallization of polymorphs CrystEngComm 11 2009 949 964
19. 2 Pharm. Res. 18 2001 682 688
20. J. Li, S.A. Bourne, and M.R. Caira New polymorphs of isonicotinamide and nicotinamide Chem. Commun. 47 2011 1530 1532
21. A. Llinàs, and J.M. Goodman Polymorph control: past, present and future Drug Discov. Today 13 2008 198 210
22. B. Lou, D. Boström, and S.P. Velaga Polymorph control of felodipine form II in an attempted cocrystallization Cryst. Growth Des. 9 2009 1254 1257
23. X. Mei, and C. Wolf Formation of new polymorphs of acridine using dicarboxylic acids as crystallization templates in solution Cryst. Growth Des. 4 2004 1099 1103
24. S. Petit, and G. Coquerel The amorphous state R. Hilfiker, Polymorphism: In the Pharmaceutical Industry 2006 Wiley-VCH Weinheim 259 285
25. S.H. Preskorn Tianeptine: a facilitator of the reuptake of serotonin and norepinephrine as an antidepressant? J. Psychiatr. Pract. 10 2004 323 330
26. S.H. Preskorn, and R. Ross Other antidepressants S.H. Preskorn, J.P. Feighner, C.Y. Stanga, R. Ross, Antidepressants: Past, Present, and Future 2004 Springer Verlag Berlin, Heidelberg 263 324
27. C.P. Price, A.L. Grzesiak, and A.J. Matzger Crystalline polymorph selection and discovery with polymer heteronuclei J. Am. Chem. Soc. 127 2005 5512 5517
28. Sansone, M., 2008. Polymorphs of 7-[(3-chloro-6,11-dihydro-6- methyldibenzo[C,f][1,2]thiazepin-11-yl)amino]heptanoic acid s,s dioxide and methods of making and using the same. US Patent No. 20,080,221,081.
29. X. Sun, B.A. Garetz, and A.S. Myerson Supersaturation and polarization dependence of polymorph control in the nonphotochemical laser-induced nucleation (NPLIN) of aqueous glycine solutions Cryst. Growth Des. 6 2006 684 689
30. I. Weissbuch, V.Y. Torbeev, L. Leiserowitz, and M. Lahav Solvent effect on crystal polymorphism: why addition of methanol or ethanol to aqueous solutions induces the precipitation of the least stable β form of glycine Angew. Chem. Int. Ed. 117 2005 3290 3293